
Inorganic Chemistry p. 6832 - 6838 (1998)
Update date:2022-08-03
Topics:
Yamami, Masako
Furutachi, Hideki
Yokoyama, Takushi
Okawa, Hisashi
A heterodinuclear ZnIIPbII complex ZnPb(L)(ClO4)2·2H2O (1) has been obtained where (L)2- is an unsymmetric macrocycle derived from the 2:1:1 condensation of 2,6-diformyl-4-methylphenol, ethylenediamine and diethylenetriamine and has the salen - and saldien -like metal-binding sites sharing the phenolic moiety. Its DMF adduct, ZnPb(L)(ClO4)2·MeOH·2DMF (1′), crystallizes in the triclinic space group P1 with a = 14.457(4) A?, b = 14.795(6) A?, c = 10.307(9) A?, α = 109.04(5)°, β = 96.24(5)°, γ = 102.56(3)°, V = 1995(2) A?3, and Z = 2. The refinement converges with R = 0.058 and Rw = 0.060 for 3532 reflections with |F0| > 3σ(|F0|). It has a discrete heterodinuclear core with the ZnII in the salen site and the PbII in the saldien site of the macrocycle (L)2-. The Zn has a square-pyramidal geometry together with a methanol oxygen, and the Pb has a seven-coordinate geometry together with one DMF oxygen and one perchlorate oxygen. The complex 1 is converted into [ZnPb(L)(OH)ClO4]H2O (2) under a weak alkaline condition. Its anhydrous form, [ZnPb(L)(OH)]ClO4 (2), crystallizes in the monoclinic space group C2/c wich a = 25.835(4) A?, b = 13.190(6) A?, c = 16.553 A?, β = 106.31(2)°, V = 5413(2) A?3 and Z = 8. The refinement converges with R = 0.038 and Rw = 0.029 for 3944 reflections with |F0| > 3σ(|F0|). It has a dimer structure of a dinuclear {ZnPb(L)(OH)}+ unit having the ZnII in the salen site and the PbII in the saldien site of the macrocycle. The hydroxide is bound to the ZnII to afford a square-pyramidal geometry about the metal. The dimeric core [ZnPb(L)(OH)]22+ is formed by the bridge of the hydroxide oxygen to the Pb* of the adjacent molecule and vice versa. The geometry about the Pb in the dimer structure is a pentagonal pyramid showing a distortion to umbrella-like structure, with the bridging hydroxide oxygen at the apex, in a DMSO solution, an equilibrium exists between the dimeric and monomeric species: [{ZnPb(L)(OH)}2]2+ ? 2[ZnPb(L)(OH)]+. On the basis of 31P NMR and visible spectra, 2 is shown to hydrolyze tris(p-nitorophenyl) phosphate (TNP) into bis(p-nitrophenyl) phosphate (BNP) in DMSO. 1 also exhibits a low activity to hydrolyze TNP into BNP due to the equilibrium [ZnPb(L)(H2O)]2+ ? [ZnPb(L)(OH)]+ + H+. From the reaction mixture with 2, a BNP complex [ZnPb(L)(BNP)]ClO4 (3) has been isolated. 3 crystallizes in the triclinic space group P1? with a = 13.494(9) A?, b = 13.88(1) A?, c = 12.765(8) A?, α = 94.71(6)°, β = 97.02(6)°, γ = 61.68(5)°, V = 2088(2) A?3, Z = 2. The refinement converges with R = 0.044 and Rw = 0.056 for 6070 reflections with |F0| > 3σ(|F0|). The BNP- group bridges the pair of metal ions through its two oxygens, together with two phenolic oxygens of (L)2-. On the basis of the above findings, a mechanistic scheme for the TNP hydrolysis by 2 is proposed; a TNP molecule is bound to the Pb center, and the hydroxide on the adjacent Zn ion attacks the phosphorus nucleus of TNP, leading to the formation of the BNP complex 3.
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Suzhou CarbonWell Pharma-Tech Co., Ltd
Contact:Tel: + 86 (0)512-8898-1216; + 86-18606258602
Address:2358 Changan Road, Wujiang Scientific Innovation Park, Wujiang, Jiangsu Province, P. R. China 215200
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
WuHan rongfashun BioChemical co., LTD
Contact:02788866139
Address:No.95 LuoYu Road,Wuhan
HK Vast Medicinal Chemistry Int'l Group Limited(expird)
website:http://www.hkvast.com/
Contact:+86-15000309979
Address:NO.6,Lane 108,Qinzhou Road,Xuhui District,Shanghai
Doi:10.1002/(SICI)1522-2675(19981007)81:10<1792::AID-HLCA1792>3.0.CO;2-Z
(1998)Doi:10.1021/ja981428p
(1998)Doi:10.1021/om980480r
(1998)Doi:10.1021/jacs.0c03926
(2020)Doi:10.1002/1099-0690(200004)2000:7<1107::AID-EJOC1107>3.0.CO;2-8
(2000)Doi:10.1039/b000355g
(2000)